Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis.
about
Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factorsMETTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-κB signaling pathway.A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the mdx Dystrophic Mouse.Muscular response to the first three months of deflazacort treatment in boys with Duchenne muscular dystrophyPalmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance.Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy.Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular DystrophyThe danger model approach to the pathogenesis of the rheumatic diseases.Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal MusclesOngoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy.Immune-mediated pathology in Duchenne muscular dystrophy.Tissue-Specific Gene Repositioning by Muscle Nuclear Membrane Proteins Enhances Repression of Critical Developmental Genes during Myogenesis.The dual CCR2/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmdmdx-4Cv) mice.Concurrent Host-Pathogen Transcriptional Responses in a Clostridium perfringens Murine Myonecrosis Infection.
P2860
Q28069464-E043C46B-97E8-4817-B237-AA4D5C9679B1Q30973924-B1346113-1E55-4607-8FFE-08BC28FF9F78Q33737817-F713394A-7CFD-470F-A93F-24A37230FB40Q33856905-774C698E-B4AC-4463-8EFA-E625A19542B5Q34105654-71923E12-9135-4CB0-A935-0168DB2A3D00Q35054988-ECC88B43-C547-4AA5-891D-036268DA5D19Q35094699-AF49548D-51DE-4FB6-830E-7ECF14BC6FBAQ35564107-FBAF1E1E-86C0-4D11-A63D-B53DB02B557AQ37589790-5CE2E01C-5C8D-4FEB-9965-106EE73BACAFQ38115148-15A26B6A-6521-48D6-8F92-79AF0D523759Q38168509-BBCBD6B0-8E9B-4A0E-BD71-7D37FD04CAA5Q38561435-D33AA263-D17C-40D1-9EAB-5BFEE3A641C4Q38766402-0F9B4055-7552-4AC0-8844-B991E457BEBAQ52644936-048DED9D-6977-4172-AF75-E198753FB611Q55115047-C74F7ED5-CD33-4C75-818C-AD27A5FB556D
P2860
Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Upregulation of chemokines and ...... enuation of myofiber necrosis.
@en
Upregulation of chemokines and ...... enuation of myofiber necrosis.
@nl
type
label
Upregulation of chemokines and ...... enuation of myofiber necrosis.
@en
Upregulation of chemokines and ...... enuation of myofiber necrosis.
@nl
prefLabel
Upregulation of chemokines and ...... enuation of myofiber necrosis.
@en
Upregulation of chemokines and ...... enuation of myofiber necrosis.
@nl
P2860
P356
P1433
P1476
Upregulation of chemokines and ...... enuation of myofiber necrosis.
@en
P2093
Jean-Jacques Martin
Kim K Creus
P2860
P304
P356
10.1002/MUS.23481
P577
2012-12-01T00:00:00Z